FDA application made for fast track for COVID-19, page-202

My excitement is on the back of Robert Murphy’s confidence in Bit225, once again it’s not the SH’s talking this up but the experts involved with Biotron. It’s obvious Biotron we’re advised to run another round of trials at the Scripps institute, because they made no ref to that on the 25th Nov 2021. It’s all about our Data set & we are talking years, Toxicology, Safety Data, 100 mg through to 600 mg, 9 human clinical trials soon to be 11 human clinical trials. I think we stand a pretty good chance of FDA approval straight up. Give me your reason why you don’t think so lol